AVEO Pharmaceuticals, Inc. - Common Stock (NQ:AVEO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 19, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AVEO Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

AVEO Oncology Announces Ficlatuzumab Granted Fast Track Designation by the U.S. FDA for the Treatment of Relapsed or Recurrent Head and Neck Squamous Cell Carcinoma

September 20, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences

August 30, 2021

From AVEO Oncology

Via Business Wire

Recap: AVEO Pharmaceuticals Q2 Earnings ↗

August 05, 2021

Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 4.76% year...

Via Benzinga

AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update

August 05, 2021

From AVEO Oncology

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

AVEO Oncology to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

July 29, 2021

From AVEO Oncology

Via Business Wire

The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix ↗

July 11, 2021

Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...

Via Benzinga

AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma

July 08, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology to Host Key Opinion Leader Webinar on Ficlatuzumab in Head and Neck Squamous Cell Carcinoma

June 07, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology to Present at the Jefferies 2021 Virtual Healthcare Conference

May 25, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Announces Presentation of Long-Term Efficacy Follow Up, Additional Tolerability Data from the Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Relapsed or Refractory Renal Cell Carcinoma

May 19, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Announces Positive Results from Randomized Phase 2 Study of Ficlatuzumab in Combination with Cetuximab in Pan-Refractory, Metastatic HNSCC

May 19, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update

May 10, 2021

From AVEO Oncology

Via Business Wire

AVEO Oncology to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 10, 2021

May 03, 2021

From AVEO Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors

April 16, 2021

From AVEO Oncology

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.